Interferon-Beta-1b Induced Autoimmune Hemolytic Anemia in a Patient with MS: A Case Report

AUTHORS

M Saeedi 1 , M Forughipour 1 , P Sasannezhad 1 , A Shoeibi 2 , *

1 Department of Neurology, Ghaem Hospital, Mashhad University of Medical Sciences, Iran

2 Department of Neurology, Ghaem Hospital, Ahmadabad Blvd, PO Box: 91766-99199, [email protected], Iran

How to Cite: Saeedi M, Forughipour M, Sasannezhad P, Shoeibi A. Interferon-Beta-1b Induced Autoimmune Hemolytic Anemia in a Patient with MS: A Case Report, Iran Red Crescent Med J. Online ahead of Print ; 13(3):210-212.

ARTICLE INFORMATION

Iranian Red Crescent Medical Journal: 13 (3); 210-212
Article Type: Case Report
Received: August 10, 2010
Accepted: November 1, 2010

Crossmark

CHEKING

READ FULL TEXT
Abstract

A 26-year old lady with the diagnosis of multiple sclerosis who had received interferon beta1-b for eleven months was visited in MS clinic of our hospital because of icter and fatigue. Laboratory tests showed anemia, indirect hyperbillirubinemia, increased LDH, positive direct and indirect coomb’s tests, and increased reticulocyte count and percentage. Other causes of autoimmune hemolytic anemia (AHA) and pre-existing AHA in the patient were ruled out. After INF discontinuation, symptoms disappeared, hemoglobin increased, and indirect coomb’s test became negative. We concluded that autoimmune hemolytic anemia should be considered in all MS patients who receive interferon beta1-b and present with symptoms and signs of anemia.

Keywords

Multiple sclerosis Interferon beta Haemolytic anemia

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: